Literature DB >> 2366131

Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy.

U Maas1, E Kattner, B Weingart-Jesse, A Schäfer, M Obladen.   

Abstract

The influence of maternal participation in a methadone detoxification program as compared to street drug use on intrauterine growth and neonatal morbidity was analysed in 75 newborns. -58 of 75 pregnant addicts joined the methadone program; in 17 women with successful prepartal detoxification, we found a longer course of pregnancy as well as normalized birth weight, head circumference and respiratory status of the neonates. The HIV-status showed no influence on prenatal growth. 63% of all infants developed a neonatal abstinence syndrome; this incidence was lower after maternal participation in the methadone detoxification program: 55 vs. 88%, p less than 0.05. Postnatal respiratory insufficiency occurred more frequently after methadone exposure than after heroin exposure before birth (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2366131     DOI: 10.1515/jpme.1990.18.2.111

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  15 in total

1.  Treatment of Prescription Opioid Use Disorder in Pregnant Women.

Authors:  Constance Guille; Kelly S Barth; Julio Mateus; Jenna L McCauley; Kathleen T Brady
Journal:  Am J Psychiatry       Date:  2017-03-01       Impact factor: 18.112

Review 2.  The management of opioid dependence during pregnancy in rural and remote settings.

Authors:  Naana Afua Jumah; Lisa Graves; Meldon Kahan
Journal:  CMAJ       Date:  2014-10-06       Impact factor: 8.262

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

Review 4.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

5.  Hyperphagia in neonates withdrawing from methadone.

Authors:  A Martinez; B Kastner; H W Taeusch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

6.  Randomized Clinical Trial of Standard- Versus High-Calorie Formula for Methadone-Exposed Infants: A Feasibility Study.

Authors:  Debra L Bogen; Barbara H Hanusa; Robyn Baker; Barbara Medoff-Cooper; Barbara Cohlan
Journal:  Hosp Pediatr       Date:  2018-01

7.  Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome.

Authors:  M H Elkomy; P Sultan; B Carvalho; G Peltz; M Wu; C Clavijo; J L Galinkin; D R Drover
Journal:  Clin Pharmacol Ther       Date:  2014-12-04       Impact factor: 6.875

Review 8.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Authors:  Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

9.  Opioid Detoxification During Pregnancy: A Systematic Review.

Authors:  Mishka Terplan; Hollis J Laird; Dennis J Hand; Tricia E Wright; Ashish Premkumar; Caitlin E Martin; Marjorie C Meyer; Hendrée E Jones; Elizabeth E Krans
Journal:  Obstet Gynecol       Date:  2018-05       Impact factor: 7.661

10.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.